EUDA — EUDA Health Holdings Income Statement
0.000.00%
- $140.12m
- $142.26m
- $3.71m
Annual income statement for EUDA Health Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 8.88 | 4.56 | 3.76 | 3.71 |
Cost of Revenue | ||||
Gross Profit | 3.89 | 1.25 | 0.87 | 0.842 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 9.66 | 5.12 | 16 | 8.31 |
Operating Profit | -0.78 | -0.56 | -12.2 | -4.61 |
Total Net Non Operating Interest Income / Expense | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 0.246 | 1.67 | -25 | -8.43 |
Provision for Income Taxes | ||||
Net Income After Taxes | 0.199 | 1.62 | -25 | -8.43 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Extraordinary Items | ||||
Net Income | 0.176 | 0.865 | -24.9 | -10 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 0.176 | 0.865 | -24.9 | -10 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.003 | 0.053 | -0.801 | -0.34 |
Dividends per Share |